Xmab 100 mg Injection
  1. Home
  2. Pharma Products
  3. RPG Life Sciences Ltd
  4. Xmab 100 mg Injection

Xmab 100 mg Injection

Xmab 100 mg Injection contains rituximab 100 mg, a monoclonal antibody used for certain blood cancers and autoimmune disorders. It targets the CD20 protein on B cells and helps reduce abnormal or overactive B-cell activity. The injection is administered by intravenous infusion under medical supervision.

BUY NOW

Category

Rituximab binds to CD20 on B cells and promotes their elimination through immune-mediated mechanisms. Xmab is used in treatment regimens for conditions including non-Hodgkin lymphoma, chronic lymphocytic leukaemia, rheumatoid arthritis, and certain vasculitis disorders. The 100 mg presentation contains 100 mg of rituximab in a 10 mL vial, providing a concentration of 10 mg/mL. Xmab 100 mg Injection is marketed by RPG Life Sciences Ltd and should be stored at 2°C–8°C without freezing.

Technical Specification

Specification Details
Active Ingredient Rituximab
Strength 100 mg
Concentration 10 mg/mL
Pack Size 10 mL vial
Dosage Form Injection
Manufacturer/Marketer RPG Life Sciences Ltd

Product Also Known As

Xmab 100 mg Injection, X-Mab 100 mg Injection, Xmab 100 mg/10 mL, Xmab 100 Injection, Xmab Rituximab Injection, Rituximab 100 mg Injection, Rituximab 100 mg/10 mL